Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Director comp.
|
|
Assertio Therapeutics, Inc (ASRT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2020 |
SC 13G
| Allianz Global Investors U.S. Holdings LLC reports a 7.3% stake in Assertio Therapeutics, Inc. |
| 11/12/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2019 |
SC 13G
| RENAISSANCE TECHNOLOGIES LLC reports a 7.3% stake in ASSERTIO THERAPEUTICS, INC. |
| 02/08/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/24/2019 |
SC 13G
| BlackRock Inc. reports a 16.3% stake in Assertio Therapeutics, Inc |
| 08/18/2017 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 6.4% stake in Depomed, Inc. |
| 02/13/2017 |
SC 13G
| OAK RIDGE INVESTMENTS LLC reports a 4.8% stake in DEPOMED INC |
| 02/08/2016 |
SC 13G
| OAK RIDGE INVESTMENTS LLC reports a 5% stake in DEPOMED INC |
| 07/19/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/27/2013 |
SC 13G
| Broadfin Capital, LLC reports a 5% stake in Depomed, Inc. |
| 02/12/2013 |
SC 13G
| DEPOMED INC reports a 5.5% stake in Depomed Inc |
| 02/09/2012 |
SC 13G
| NORTHPOINTE CAPITAL LLC reports a 8.3% stake in Depomed, Inc |
| 11/29/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/25/2011 |
SC 13G
| DEPOMED INC reports a 6% stake in DEPOMED, INC. |
| 03/04/2010 |
SC 13G
| DEPOMED INC reports a 5.2% stake in Depomed, Inc. |
| 01/29/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|